Pacer Advisors Inc. reduced its position in shares of MetLife, Inc. (NYSE:MET - Free Report) by 29.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 67,981 shares of the financial services provider's stock after selling 28,845 shares during the period. Pacer Advisors Inc.'s holdings in MetLife were worth $5,566,000 as of its most recent SEC filing.
A number of other hedge funds have also recently added to or reduced their stakes in the company. Zurich Insurance Group Ltd FI purchased a new stake in shares of MetLife in the third quarter valued at $91,771,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its holdings in shares of MetLife by 79.1% during the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 1,726,209 shares of the financial services provider's stock worth $142,378,000 after buying an additional 762,291 shares in the last quarter. Jacobs Levy Equity Management Inc. grew its stake in MetLife by 256.6% in the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 948,223 shares of the financial services provider's stock worth $78,209,000 after acquiring an additional 682,333 shares during the period. Nordea Investment Management AB raised its holdings in MetLife by 16.8% in the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider's stock valued at $347,735,000 after acquiring an additional 608,224 shares during the last quarter. Finally, SG Americas Securities LLC lifted its stake in shares of MetLife by 107.5% during the 4th quarter. SG Americas Securities LLC now owns 30,542 shares of the financial services provider's stock worth $2,501,000 after purchasing an additional 435,807 shares during the period. Institutional investors and hedge funds own 94.99% of the company's stock.
MetLife Stock Up 0.5 %
Shares of MET traded up $0.43 during mid-day trading on Thursday, reaching $87.07. 2,178,466 shares of the stock traded hands, compared to its average volume of 3,530,110. The stock has a fifty day simple moving average of $84.03 and a 200 day simple moving average of $80.35. MetLife, Inc. has a 12-month low of $64.61 and a 12-month high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The firm has a market cap of $60.29 billion, a price-to-earnings ratio of 17.55, a P/E/G ratio of 0.65 and a beta of 1.07.
MetLife Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 11th. Investors of record on Tuesday, February 4th will be issued a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a yield of 2.50%. The ex-dividend date of this dividend is Tuesday, February 4th. MetLife's dividend payout ratio is currently 43.95%.
Analyst Ratings Changes
Several equities analysts recently commented on the company. Barclays upped their target price on MetLife from $90.00 to $96.00 and gave the company an "overweight" rating in a research note on Monday, January 6th. Wells Fargo & Company cut their price target on shares of MetLife from $93.00 to $92.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 14th. JPMorgan Chase & Co. boosted their price objective on shares of MetLife from $86.00 to $88.00 and gave the company an "overweight" rating in a research note on Tuesday, January 7th. BMO Capital Markets started coverage on MetLife in a report on Thursday, January 23rd. They issued a "market perform" rating and a $97.00 target price on the stock. Finally, TD Cowen boosted their price target on MetLife from $97.00 to $99.00 and gave the company a "buy" rating in a research report on Wednesday, November 27th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $90.46.
Read Our Latest Stock Analysis on MET
About MetLife
(
Free Report)
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
See Also
Before you consider MetLife, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.
While MetLife currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.